Medicago’s Canada-made COVID-19 vaccine approved by Health Canada

The vaccine is a two-dose regimen that must be administered 21 days apart, based on evidence from clinical trials.

(Irylene Lavery/ Global News) — The first Canadian COVID-19 vaccine, by Quebec-based company Medicago, was approved for use by Health Canada Thursday.

The home-grown vaccine, called Covifenz, marks the world’s first-ever plant-based jab authorized for human use and is also the first Canadian shot to be approved in over 20 years.

The vaccine has been approved for people aged between 18 and 64 after clinical trials showed a 71 per cent effectivity rate in protecting trial participants in that age group against COVID-19, Health Canada said in a press release. (…)

Categories

Categories